We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $38.9B
1-Year Est. Return 28.51%
This Fund
S&P 500
This Quarter Est. Return
+14.95%
1 Year Est. Return
+28.51%
3 Year Est. Return
+113.74%
5 Year Est. Return
+119.24%
10 Year Est. Return
+611.73%
AUM
$38.9B
AUM Growth
+$3.48B
Cap. Flow
-$847M
Cap. Flow %
-2.18%
Top 10 Hldgs %
22.43%
Holding
846
New
241
Increased
167
Reduced
189
Closed
194

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$1.48B
2
NVDA icon
NVIDIA
NVDA
+$925M
3
AMZN icon
Amazon
AMZN
+$657M
4
HOOD icon
Robinhood
HOOD
+$618M
5
CSCO icon
Cisco
CSCO
+$334M

Sector Composition

Rank Sector Weight
1 Technology 24.88%
2 Industrials 13.79%
3 Healthcare 11.67%
4 Consumer Discretionary 10.83%
5 Miscellaneous 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVCT icon
501
Nuvectis Pharma
NVCT
$660M
$5.06M 0.01%
+275,000
New +$3.08M
JCAP
502
Jefferson Capital
JCAP
$1.12B
$5.03M 0.01%
258,318
+11,246
+5% +$210K
AKAM icon
503
Akamai
AKAM
$16.4B
$4.98M 0.01%
42,157
-590,993
-93% -$73.6M
DEC
504
Diversified Energy Company
DEC
$976M
$4.96M 0.01%
357,929
+125,204
+54% +$1.89M
AXSM icon
505
Axsome Therapeutics
AXSM
$10.2B
$4.92M 0.01%
+20,091
New +$4.36M
NEOV icon
506
NeoVolta
NEOV
$129M
$4.88M 0.01%
+1,550,000
New +$3.93M
ARWR icon
507
Arrowhead Research
ARWR
$9.31B
$4.79M 0.01%
58,722
-414,148
-88% -$30.6M
HUMA icon
508
Humacyte
HUMA
$155M
$4.7M 0.01%
+6,022,925
New +$5.58M
COYA icon
509
Coya Therapeutics
COYA
$119M
$4.68M 0.01%
800,000
– –
QLYS icon
510
Qualys
QLYS
$5.97B
$4.62M 0.01%
33,624
-271,053
-89% -$26.7M
PTC icon
511
PTC
PTC
$15B
$4.6M 0.01%
40,502
-77,572
-66% -$10.5M
TMS
512
Teamshares Inc
TMS
$592M
$4.47M 0.01%
+543,748
New +$5.49M
SPRB
513
Spruce Biosciences
SPRB
$140M
$4.41M 0.01%
81,671
+30,000
+58% +$1.68M
CGON icon
514
CG Oncology
CGON
$5.95B
$4.39M 0.01%
+61,729
New +$4.04M
LYTS icon
515
LSI Industries
LYTS
$786M
$4.36M 0.01%
164,170
-135,830
-45% -$3.14M
BRCC icon
516
BRC Inc
BRCC
$131M
$4.36M 0.01%
392,712
-568,831
-59% -$7.04M
ABX
517
Abacus Global Management
ABX
$811M
$4.32M 0.01%
403,061
-473,555
-54% -$4.33M
OBIO icon
518
Orchestra BioMed
OBIO
$358M
$4.32M 0.01%
1,000,000
– –
BOW
519
Bowhead Specialty Holdings
BOW
$1.11B
$4.23M 0.01%
141,282
– –
INN
520
Summit Hotel Properties
INN
$619M
$4.2M 0.01%
598,819
– –
CMCL icon
521
Caledonia Mining Corp
CMCL
$461M
$4.15M 0.01%
217,354
-185,360
-46% -$4.21M
ABCL icon
522
AbCellera Biologics
ABCL
$4.12B
$4.13M 0.01%
526,577
-2,065,528
-80% -$10.1M
MDA
523
MDA Space Ltd
MDA
$5.11B
$4.13M 0.01%
100,000
-275,000
-73% -$9.98M
SMTC icon
524
Semtech
SMTC
$17B
$4.12M 0.01%
+25,427
New +$3.32M
FLS icon
525
Flowserve
FLS
$9.38B
$4.05M 0.01%
+54,603
New +$4.15M

Similar funds

Alyeska Investment Group's Q2 2026 Portfolio in Review

As of Q2 2026, Alyeska Investment Group held 846 positions worth $38.9B, up 9.8% from $35.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Alyeska Investment Group's Q2 2026 filing shows 241 new, 167 increased, 189 reduced and 194 closed positions. Its largest new stake was Salesforce: 4,662,005 shares worth $730M. The largest sale was Micron Technology, an estimated $1.48B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Alyeska Investment Group's largest Q2 2026 buy was Salesforce: 4,662,005 shares worth $730M.
  • Alyeska Investment Group added most to CoreWeave in Q2 2026, an estimated $421M increase.
  • Alyeska Investment Group's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.48B.
  • Alyeska Investment Group fully exited Cisco in Q2 2026, selling an estimated $334M.
  • Alyeska Investment Group's ten largest holdings make up 22% of its $38.9B portfolio in Q2 2026.
  • Alyeska Investment Group opened 241 new positions and closed 194 in Q2 2026.
  • Alyeska Investment Group's portfolio value rose 9.8% quarter-over-quarter to $38.9B.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.